John Digrazia
Interventional Cardiology · Richmond, VANPI 1376578765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 106 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $726 and has fallen 53.4% since, to $338 in 2022. That places this record below the midpoint for interventional cardiology clinicians in VA, where the typical reported total is $4,743.
Across 106 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$388
- Boehringer Ingelheim$245
- Johnson & Johnson$193
- Abiomed$149
- Sanofi-aventis U.S. LLC$145
- Amgen$138
- plus $804 from 20 others
What the payments were for
- Consulting fees$121%
- Food & beverage$2,04999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 22 | $388 |
| Boehringer Ingelheim | 9 | $245 |
| Johnson & Johnson | 13 | $193 |
| Abiomed | 1 | $149 |
| Sanofi-aventis U.S. LLC | 9 | $145 |
| Amgen | 8 | $138 |
| Pfizer | 6 | $107 |
| Abbott | 5 | $98 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 4 | $64 |
| Impulse Dynamics (USA) Inc. | 2 | $62 |
| Cardiovascular Systems Inc. | 1 | $46 |
| Boston Scientific | 2 | $44 |
| Merck | 3 | $40 |
| E.r. Squibb & Sons, L.L.C. | 3 | $36 |
| AstraZeneca(2 entities) | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $30 |
| Sanofi | 1 | $22 |
| Bardy Diagnostics, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $16 |
| Cardiva Medical, Inc. | 1 | $15 |
| Itamar Medical Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,061 in reported general payments places this provider in the 30th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Richmond
- Gansevoort DunningtonRichmond$440K
- Matthew ChungRichmond$75K
- Ashwani KumarRichmond$35K
- Brinder KandaRichmond$34K
- James GarnettRichmond$19K
- Barbara LawsonRichmond$17K
- John PosenauRichmond$11K
- Michael ArcareseRichmond$10K
- Sam DowRichmond$10K
- Deepak TalrejaVirginia Beach$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.